352343 <common-name>7-[[4,6-bis[4-(2-aminoethyl)piperazin-1-yl]-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[(4-methoxyphenyl)diazenyl]naphthalene-2-sulfonic acid</common-name> <description>7-[[4,6-bis[4-(2-aminoethyl)piperazin-1-yl]-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[(4-methoxyphenyl)diazenyl]naphthalene-2-sulfonic acid has the chemical formula C32H42N12O5S. With an average molecular weight of 706.80 g/mol, 7-[[4,6-bis[4-(2-aminoethyl)piperazin-1-yl]-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[(4-methoxyphenyl)diazenyl]naphthalene-2-sulfonic acid is a heavy molecule.</description> <cas nil="true"/> <pubchem-id>136125622</pubchem-id> <chemical-formula>C32H42N12O5S</chemical-formula> <weight>706.8</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T18:37:04Z</created-at> <updated-at type="dateTime">2026-08-31T18:37:04Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>COC1=CC=C(C=C1)N=NC2=C(C=C3C=C(C=CC3=C2O)NC4=NC(=NC(=N4)N5CCN(CC5)CCN)N6CCN(CC6)CCN)S(=O)(=O)O</moldb-smiles> <moldb-formula>C32H42N12O5S</moldb-formula> <moldb-inchi>InChI=1S/C32H42N12O5S/c1-49-25-5-2-23(3-6-25)39-40-28-27(50(46,47)48)21-22-20-24(4-7-26(22)29(28)45)35-30-36-31(43-16-12-41(10-8-33)13-17-43)38-32(37-30)44-18-14-42(11-9-34)15-19-44/h2-7,20-21,45H,8-19,33-34H2,1H3,(H,46,47,48)(H,35,36,37,38)</moldb-inchi> <moldb-inchikey>FPNRACZKRATPGX-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">706.3121837</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>-0.4</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM348236</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>7-[[4,6-bis[4-(2-aminoethyl)piperazin-1-yl]-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[(4-methoxyphenyl)diazenyl]naphthalene-2-sulfonic acid</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Benzenoids</superklass> <klass>Naphthalenes</klass> <subklass>Naphthalene sulfonic acids and derivatives</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0302632</sync-id> <structure-inchikey>FPNRACZKRATPGX-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>2080000000000000000000000000018020000000000000000000000000000020400002000000200080010000000000000000000010000000000000000000000000800000202000002000000000010000020400000000000004000001000001085000000010000000000002910000040000040000000000000000004002000000000000000000408000100000000000000000000080000000000000000000080004000008000000010000400000000008a0004008000000a0040000000320002000000000000000480080000000000004000200000000010000000000008003000040000080021000000000000000000000000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAyAAAANwAAAIABBgBgAAAAAQMIACgAAAAD AgZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQGQGgAAAADAwEG QGgAAAADAwEHACgAAAADAwcAKAAAAAMDBkAoAAAAAwQGQCgAAAADBAZAaAAA AAMDAQZAKAAAAAMEBkBoAAAAAwMBBkAoAAAAAwQGQGgAAAADAwEGQGgAAAAD AwEGQCgAAAADBAZAKAAAAAMECABoAAAAAwEBBwBoAAAAAwIBBkAoAAAAAwQH QCgAAAADAwZAKAAAAAMEB0AoAAAAAwMGQCgAAAADBAdAKAAAAAMDBwAoAAAA AwMGAGAAAAACAgYAYAAAAAICBwAgAAAAAwYAYAAAAAICBgBgAAAAAgIGAGAA AAACAgYAYAAAAAICBwBgAAAAAQIHACgAAAADAwYAYAAAAAICBgBgAAAAAgIH ACAAAAADBgBgAAAAAgIGAGAAAAACAgYAYAAAAAICBgBgAAAAAgIHAGAAAAAB AhAAIAAAAAYIACgAAAADAggAKAAAAAMCCABgAAAAAQELAAEAAQIgAgNoDAME aAwEBWgMBQZoDAYHaAwFCCAICSgCCQogCgtoDAsMaAwMDWgMDQ5oDA4PaAwP EGgMEBFoDBESaAwSE2gMExQgDxUgFRYgFhdoDBcYaAwYGWgMGRpoDBobaAwa HCAcHQAdHgAeHwAfIAAgIQAfIgAiIwAjJAAYJSAlJgAmJwAnKAAoKQApKgAo KwArLAAsLQALLgAuLwgCLjAIAi4xAAcCaAwTCmgMEg1oDBsWaAwhHAAqJQBC BgAAAAYCBwYFBAMGCwwNEhMKBg4PEBESDQYXGBkaGxYGHR4fICEcBiYnKCkq JRcEAAAAAAAAABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:50:06Z</structure-indexed-at> </compound>